Page last updated: 2024-10-18

glycine and Hyperlipoproteinemia Type I

glycine has been researched along with Hyperlipoproteinemia Type I in 2 studies

Hyperlipoproteinemia Type I: An inherited condition due to a deficiency of either LIPOPROTEIN LIPASE or APOLIPOPROTEIN C-II (a lipase-activating protein). The lack of lipase activities results in inability to remove CHYLOMICRONS and TRIGLYCERIDES from the blood which has a creamy top layer after standing.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sprecher, DL1
Harris, BV1
Stein, EA1
Bellet, PS1
Keilson, LM1
Simbartl, LA1
Faustinella, F1
Chang, A1
Van Biervliet, JP1
Rosseneu, M1
Vinaimont, N1
Smith, LC1
Chen, SH1
Chan, L1

Other Studies

2 other studies available for glycine and Hyperlipoproteinemia Type I

ArticleYear
Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report.
    Circulation, 1996, Dec-15, Volume: 94, Issue:12

    Topics: Adult; Blood Pressure; Body Mass Index; Cholesterol, LDL; Exons; Genetic Carrier Screening; Glutamic

1996
Catalytic triad residue mutation (Asp156----Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447----Ter) in a Turkish family.
    The Journal of biological chemistry, 1991, Aug-05, Volume: 266, Issue:22

    Topics: Adipose Tissue; Alleles; Aspartic Acid; Base Sequence; Catalysis; DNA; Glycine; Humans; Hyperlipopro

1991